Journal Menu
► ▼ Journal Menu-
- Biomolecules Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Early Career Editorial Board
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
2 July 2026
MDPI INSIGHTS: The CEO’s Letter #36 – Basel Anniversary Summit, 2025 Impact Factors & CiteScores, CSAL Partnership & ncRNA2026
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts

Reflections from the MDPI 30th Anniversary Summit in Basel
On 4 June, we welcomed 30 Editors-in-Chief (EiCs) from across Europe, North America, and Asia-Pacific to A 66, MDPI’s former headquarters in Basel, for our 30th Anniversary Summit.
In the middle of the year that we celebrate 30 years since MDPI’s founding in 1996, the Summit provided an opportunity to reflect on our journey and recognize the academic community that has helped shape MDPI over the past three decades.
Designed as a small invitation-only event, the Summit brought together long-standing editorial leaders whose experience and perspectives continue to shape our journals. Throughout the day, one message emerged consistently: strong journals are built together, through partnership between publishers, editors, reviewers, and researchers.
MDPI at 30
During my opening presentation, I reflected on MDPI’s evolution from a single journal (Molecules) to a global Open Access (OA) publisher supporting more than 500 peer-reviewed journals, thousands of editors, and millions of researchers worldwide.
While our growth has been significant, our purpose remains unchanged: to help researchers communicate their work openly, efficiently, and responsibly.

I also took the opportunity to recognize that MDPI’s success has never been achieved alone. It has been built alongside our EiCs, Editorial Board Members, reviewers, authors, institutional partners, and colleagues around the world.
Agenda
The agenda combined moments for reflection, discussion, and direct engagement with our guests. The event was moderated by Damaris Critchlow (Editorial Engagement Manager, MDPI) and the program focused on dialogue rather than presentations alone, combining expert talks, panel discussions, and open forums covering:
- MDPI at 30: reflections and the road ahead
- Research integrity and editorial responsibility
- Partnerships and collaboration in publishing
- Editorial leadership and journal development
- Artificial intelligence and the future of scholarly publishing
|
|
|
|
|
|
|
|
|
|
Research Integrity and Editorial Responsibility
A key theme throughout the summit was the continued importance of research integrity and editorial independence. Tim Tait-Jamieson provided an overview of MDPI’s approach to publication ethics, emerging industry challenges, and ongoing investments in prevention, detection, and post-publication oversight. This was a key topic, as it created discussions on the evolving role of publishers, editors, and institutions in safeguarding the scientific record while maintaining transparency and trust.

Editors Panel: Building Journals and Communities
The EiC panel focused on the role of editorial leadership in developing journals and academic communities. Discussions highlighted the importance of active editorial boards, constructive peer review, community engagement, and maintaining quality as scholarly publishing continues to evolve. Thank you to our panelists: Dr. Ester Ballana (Viruses), Dr. Dilantha Fernando (Plants), and Dr. Ting Chi (Journal of Theoretical and Applied Electronic Commerce Research).

MDPI Panel: The Future of Scholarly Publishing
We also had a roundtable discussion on the future of scholarly publishing. Topics included:
- Artificial intelligence and its role in publishing workflows
- Technology and innovation in scholarly communication
- Research integrity and quality assurance
- The future of peer review
- Open Access and Open Science
- The evolving expectations of researchers, institutions, and funders
|
|
|
|
Recognizing Editorial Leadership
A highlight of the Summit was recognizing EiCs whose long-term leadership has helped strengthen both their journals and their research communities.
Through the Decade of Editorial Leadership Award and the Outstanding Editorial Impact Award, we celebrated individuals whose dedication has made a lasting contribution to scientific publishing.
|
|
|
|
As we look ahead to MDPI’s next chapter, partnerships with our editors and the wider academic community will remain central to everything we do.
Thank You
My sincere thanks to everyone who participated, and to the many colleagues whose planning and commitment made the Summit such a memorable event.
|
|
|
|
|
Impactful Research

2025 Impact Factors Released
June marked another important milestone, with the release of the 2025 Journal Citation Reports (JCR).
Learn more: https://www.mdpi.com/about/announcements/17055
This year:
- 330 MDPI journals received a Journal Impact Factor
- 254 journals increased their Impact Factor
- 29 journals received their first Journal Impact Factor
- 71% of ranked journals are now positioned in Q1 or Q2
- MDPI publications have now accumulated 25 million citations
While journal metrics should never be viewed as the sole measure of research quality, they remain an important indicator of journal visibility, community engagement, and scientific influence.
These achievements reflect the collective work of our Editors-in-Chief, Editorial Board Members, reviewers, authors, Publishing teams, and everyone involved in developing our journals.
Congratulations to every journal team that contributed to these results.
Inside MDPI

MDPI Journals Receive 2025 CiteScores
In June, Scopus published the 2025 CiteScores, providing another positive indication of the continued development of MDPI journals.
You can find more details about the 2025 CiteScore release here: Open Access, Broadly Recognized: 363 MDPI Journals Receive CiteScores for 2025
This year’s highlights include:
- 363 journals received a CiteScore
- 41 journals received a CiteScore for the first time
- 314 journals (86%) rank in Q1 or Q2
- 42 journals are now within the top 10% of their subject categories
Although no single metric defines journal quality, these results demonstrate the continued recognition and visibility of our journals across many research disciplines.
Particularly encouraging is the growing number of journals receiving their first CiteScore, reflecting years of sustained editorial development, successful indexing, and close collaboration between our Publishing teams, Indexing team, editors, and academic communities.
Thank you to everyone across MDPI whose daily work contributes to these achievements.
Coming Together for Science

Supporting Open Access in Switzerland: MDPI Renews Agreement with CSAL
I am pleased to share that MDPI has renewed its Open Access (OA) publishing agreement with the Consortium of Swiss Academic Libraries (CSAL), extending support for researchers across 24 Swiss institutions through our Institutional Open Access Program (IOAP).
As a Swiss-founded publisher, we are particularly proud to continue supporting Switzerland’s research community through long-term institutional partnerships that improve accessibility to Open Access publishing.
The renewal also coincides with the release of our 2025 Switzerland Country Report, highlighting continued national leadership in Open Science. Between 2021 and 2025, Switzerland maintained an OA publication rate of approximately 65–70%, while more than 14,000 Switzerland-affiliated papers have been published with MDPI since 2021.
“We are particularly proud to continue supporting Switzerland’s research community”
The announcement also received coverage across several leading international publishing and research news platforms, including STM, Research Information, EurekAlert!, Bytes Europe, and EdTech Innovation Hub, helping increase visibility for both the partnership and the broader discussion around OA.
My thanks to our IOAP, External Affairs, Communications, and Publishing teams, whose work continues to strengthen relationships with institutions around the world.
Closing Thoughts

Highlights from MDPI Conference ncRNA2026 in Leuven, Belgium (24–26 June)
From 24–26 June, MDPI hosted the ncRNA2026: From Molecular Mechanisms to Clinical Impact Conference in Leuven, Belgium.
The conference welcomed 125 participants from 22 countries and territories, providing an international forum for exchange across molecular biology, medicine, biotechnology, artificial intelligence, and translational research.

Bringing the Global Research Community Together
Over three days, participants exchanged ideas through:
- 4 Chair Talks
- 8 Invited Lectures
- 29 Selected Oral Presentations
- 51 Poster Presentations
Sessions covered topics including molecular biology, clinical applications, artificial intelligence, and emerging non-coding RNA research, creating a dynamic forum for scientific exchange.
|
|
|
Beyond the scientific program, the conference created opportunities for researchers, journal teams, sponsors, and academic partners to exchange ideas, build existing relationships, and create new collaborations across the global research community.
|
|
|
Our thanks to Conference Chairs Professors George Calin, Manuela Ferracin, Eleonora Leucci, and Isidore Rigoutsos, together with the invited speakers, for delivering an outstanding scientific program.
|
|
|
“By creating opportunities for researchers to exchange ideas, we continue to support the advancement of research worldwide”
Recognizing the Team
The conference also took place during an exceptional heatwave in Belgium, with temperatures reaching 38°C. Thanks to the excellent planning by the Conference team and collaboration with the venue, additional cooling measures and attendee support ensured that the event ran safely and successfully despite challenging conditions.
|
|
|
|
It is often these behind-the-scenes efforts that make the greatest difference to the participant experience. Thank you to everyone involved for your professionalism, flexibility, and commitment throughout the event.
Thank You
My sincere thanks to the Conference Chairs, invited speakers, sponsors, Editorial Office, Conference team, Marketing colleagues, volunteers, and everyone who contributed to making ncRNA2026 such a success.

As MDPI celebrates its 30th anniversary, events such as ncRNA2026 remind us that our contribution extends well beyond publishing journals. By creating opportunities for researchers to exchange ideas, establish collaborations, and build scientific communities, we continue to support the advancement of research worldwide.
Thank you for your continued dedication throughout another busy month, and I wish you all an enjoyable July!
Chief Executive Officer
MDPI AG
29 June 2026
Biomolecules Receives an Updated Impact Factor of 5.6
We are pleased to share that Biomolecules (ISSN 2218-273X) was awarded an increased Impact Factor of 5.6 in the 2025 Journal Citation Reports™ released by Clarivate™ in June 2026. Biomolecules ranks in Q1 (72 among 328 titles) in the “Biochemistry & Molecular Biology” category.
The 2025 Journal Impact Factor is calculated by dividing the number of citations received in 2025 to all publications in the journal from 2023 and 2024 by the total number of citable publications from those same years.
To learn more, visit our journal statistics website for detailed metrics or check out our news article for general information.
The support and dedication of all the editors, reviewers, authors, and readers are an integral part of the journal’s performance. We would like to take this opportunity to thank all of you who have contributed to the journal.
17 June 2026
2025 Impact Factors Released
Impact Factors measure how often articles in scientific journals are cited—specifically, the average number of citations received in a given year by articles published in that journal over the previous two years, as tracked in the Web of Science. For researchers, the number answers a practical question: how often is work published in this journal being picked up and built upon?
The metric is assigned to the journal as a whole, not to individual articles. A high Impact Factor tells you something useful about a journal's place in its field; it tells you less about any single paper within it.
For a complementary, article-level view, MDPI lists an Altmetric score on each article page. Where the Impact Factor tracks academic citations, the Altmetric score captures broader online attention: how an article is being shared, discussed, and referenced beyond the journal literature. Together, they offer two different ways of asking the same question: is this research reaching people?
With 2025 CiteScores from Scopus published a few weeks ago, Clarivate has now released this year's Journal Impact Factors in the Journal Citation Reports (JCR).
254 MDPI Journals Saw a Rise in Impact Factor
This year's JCR include 330 MDPI journals across a wide range of disciplines. Of these, 231 journals are placed in the top 50% (Q1 or Q2) of their respective subject categories, a result that spans fields as different as materials science, public health, environmental studies, and mathematics. 78 journals hold a top-quartile position (Q1), and 33 journals have a JIF of 5.0 or above.
- 330 journals earned a Journal Impact Factor (JIF)
- 29 journals earned a first JIF
- 254 journals had an increase in JIF
- 71% of ranked journals are in Q1 or Q2
For the full metrics on any MDPI journal, visit our Web of Science journals overview page or a journal's individual statistics page.
29 MDPI Journals Received Their First Journal Impact Factor
A first Impact Factor is a confirmation for an emerging journal. It marks the point at which a journal has been publishing long enough, and cited broadly enough, to enter the formal record of scientific influence. For the research communities those journals serve, it signals that the work being published is being read and built upon.
This year, 29 MDPI journals received a Journal Impact Factor for the first time, across a range of emerging and established research areas. Each represents years of editorial development and peer review—recognized in 2026 for the first time in the JCR.
This is also part of a longer shift in how science gets indexed. When the Emerging Sources Citation Index (ESCI) launched in 2016, 24 MDPI journals were included. By 2024 that number had grown to over 200, reflecting a broader change in the visibility of open access publishing within major citation tracking systems, not just at MDPI but across the sector.
Open Access with Impact
MDPI journals have received a total of 25.2 million citations in Web of Science. That figure matters less as a measure of MDPI's reach and more as a measure of what happens when research is freely available: it gets found, read, and used. Open access is only meaningful if the work actually travels and citations are one indicator that it does.
More than 4.6 million authors have published with MDPI. That breadth, across disciplines, institutions, and geographies, is what makes open access at this scale worth doing.
Thank You to the MDPI Scholarly Community
These results belong to the people who do the actual work: the Editors-in-Chief who set the standards, the Editorial Board Members and reviewers who hold them, and the authors who choose open access for their research. The numbers in the Journal Citation Reports are the downstream effect of decisions made at the desk, in the review, and at submission. Thank you for making them.
Data: 2025 Journal Impact Factors, Journal Citation Reports™ (Clarivate, 2026)
16 June 2026
Biomolecules Receives an Increased CiteScore of 9.3
We are pleased to share that Biomolecules (ISSN 2218-273X) has received an increased CiteScore of 9.3 in June 2026. The CiteScore ranks the journal 63 out of 448 titles (Q1) in the “Biochemistry” category, and 77 out of 414 titles (Q1) in the “Molecular Biology” category, an impressive achievement for a journal running in Volume 15.
You can find more statistics on our website.
The current CiteScores measure the average number of citations within a journal over a four-year window (2022–2025). The Scopus database provides a comprehensive suite of metrics that support informed publishing strategies, research evaluation and enable benchmarking of journal performance.
This achievement reflects the collective efforts of our authors, reviewers, and editors. Together we will continue to track the progress of Biomolecules and its growing impact in molecular and cell biology.
8 June 2026
Meet Us at the 2026 Human Proteome Organization World Congress, 27 September–1 October 2026, Singapore
Conference: 2026 Human Proteome Organization World Congress
Date: 27 September–1 October 2026
Location: Singapore
From 27 September to 1 October 2026, MDPI will be attending the 2026 Human Proteome Organization World Congress (HUPO 2026) in Singapore as an exhibitor, welcoming researchers from diverse backgrounds to visit and share their latest ideas.
This year, HUPO 2026 are embracing the theme “Proteomics Plus: Transforming Lives” and are excited to explore how proteomics is shaping the future of health and medicine in ways we could have only dreamed of a few years ago. Proteomics is no longer just a field of study; it is a catalyst for change. From cutting-edge breakthroughs to real-world solutions, the impact of proteomics is undeniable. At this Congress, we will come together to celebrate how our work is transforming lives—from advancing medical treatments to uncovering new ways to understand health on a global scale. It is an opportunity to see how the science is evolving and, most importantly, how it is making a real difference in people’s lives.
We look forward to meeting you in Singapore for an unforgettable experience at HUPO 2026!
The following MDPI journals will be represented:
If you attend this conference, please feel free to visit our booth. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the official website: https://2026.hupo.org/.
4 June 2026
Open Access, Broadly Recognized: 363 MDPI Journals Receive CiteScores for 2025
The 2025 CiteScore metrics have been officially released by Scopus, and the results confirm what has become a consistent pattern for MDPI's journal portfolio: broad recognition across disciplines, steady improvement across the majority of ranked titles, and a growing presence at the top of subject category rankings.
CiteScore, published annually by Elsevier's Scopus database, measures the average citations received by articles published in a journal over a four-year window. As a complement to the Journal Impact Factor, which uses a two-year window based on the Web of Science database, CiteScore provides an alternative, long-term perspective on citation performance.
The 365 MDPI journals in Scopus (as of May 2026) are indexed across a wide range of subject categories, ensuring that open access research remains highly discoverable to a global readership through one of the most widely used platforms in academic publishing.
Data Summary (2025 CiteScores)
- New Additions: 41 MDPI journals received a CiteScore for the first time.
- Trending Upward: 234 of 322 previously ranked journals (73%) saw an increase in their CiteScore compared to last year.
- High Visibility: 314 journals (86%) rank in Q1 or Q2 in at least one subject category.
- Elite Performance: 42 journals rank in the top 10% of their subject categories.
Portfolio Performance
Among the 322 journals that held a CiteScore in 2024, 234 saw an increase this year. Quartile improvements outnumbered declines across the portfolio, with 52 journals moving to a higher quartile and only 20 seeing a decline. Furthermore, no previously ranked journals were removed. The 42 journals now ranked in the top 10% of their subject categories are drawn from a strong foundation of 178 journals holding a Q1 position.
With the large majority of our indexed portfolio ranked in the top half of research fields, researchers can confidently choose MDPI to meet funder mandates for high-quality, fully compliant Open Access publishing.
Exceptional Achievements for Foods and Life
Notably, both Foods and Life achieved a 99th percentile ranking in their respective subject categories for the 2025 CiteScores. This outstanding placement positions them as leading journals in their fields and highlights the high visibility and global impact of the open access research they publish.
Journal Metrics and Beyond
Journal-level metrics describe outlets, not individual articles. An increasing number of funders and institutions—including signatories of DORA and the Coalition for Advancing Research Assessment—now explicitly encourage evaluation at the article level rather than by the journal in which research appears. MDPI supports this direction: we report CiteScore alongside the Journal Impact Factor, Journal Citation Indicator, and article-level usage data because no single number captures the full reach and contribution of published research.
Thank You
These results reflect the sustained effort of thousands of editors-in-chief, editorial board members, reviewers, and authors across every field MDPI serves. The metrics are the outcome; the work is yours.
1 June 2026
MDPI INSIGHTS: The CEO’s Letter #35 – 30 Years of Open Science, Open Access Policies, Spain Summit, MMCS 2026 & Antibiotics 2026
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts

30 Years of Open Science, Built Together
This month, we officially launched MDPI’s 30th Anniversary campaign and dedicated anniversary website, marking an important milestone in our journey as an open access publisher. What began in 1996 with a single journal and the simple belief that scientific knowledge should be shared openly and freely has grown into a global publishing organization supporting more than 500 journals, 68,000 Editorial Board Members, and millions of researchers worldwide.
The anniversary page, entitled 30 Years of Open Science, Built Together, reflects on the people, milestones, and partnerships that have shaped MDPI over the past three decades. It includes a retrospective of our development, key moments in the evolution of open access, landmark research articles, journal anniversaries, an interview with the CEO, and perspectives from colleagues and partners who have contributed to our success.

Looking back, one of the most striking aspects of our journey is not simply our growth, but the broader transformation of scholarly publishing itself.
Open access has moved from a niche concept to a widely adopted publishing model, helping make research more accessible, discoverable, and impactful for researchers, institutions, policymakers, and society.
MDPI has been part of this transition and continues to invest in the people, technology, partnerships, and research integrity infrastructure needed to support high-quality open science at scale.
While anniversaries naturally encourage reflection, they are also an opportunity to look ahead. The challenges facing scholarly publishing today, including research integrity, artificial intelligence, accessibility, and global participation in science, will require continued collaboration across the research ecosystem. As we celebrate 30 years of publishing, our focus remains on supporting researchers, strengthening trust in open science, and helping shape the future of scholarly communication together.
I encourage you to visit the anniversary page, explore the milestones, and take a moment to reflect on the role each of us has played in contributing to MDPI’s story.
Thank you for being part of this journey.
Impactful Research

Highlights from MMCS 2026 in Beijing (14-17 May)
From 14–17 May, MDPI hosted The 5th Molecules Medicinal Chemistry Symposium (MMCS 2026) in Beijing, China, bringing together academia and industry to explore advances in chemical biology, medicinal chemistry, and drug discovery.
The conference hosted more than 230 attendees from 37 countries and regions, alongside 257 submissions and 145 accepted abstracts. With a significant increase in attendance – up by 100 participants compared with the previous edition – the popularity of MMCS continues to grow in terms of its international profile and scientific relevance within this rapidly evolving field.

The scientific program covered seven themes:
- Chemical Biology for Drug Discovery
- Medicinal Chemistry Research Progress
- Natural Products in Drug Discovery
- AI-enabled Drug Discovery
- GPCR & Ion Channel Targeted Drug Development
- Innovative Proximity-Based Drug Modalities
- Biocatalysis for Natural Product & Drug Synthesis
The event featured three plenary speakers, 14 keynote speakers, 35 selected oral presentations, and 98 poster presentations, creating opportunities for open scientific exchange and collaboration. Conference Chair Prof. Dr. Diego Muñoz-Torrero described this edition as one of the most successful MMCS events to date.
|
|
|
Thanks to our Sponsors
MMCS 2026 secured sponsorship support from 12 industrial partners, 11 of which set up on-site exhibition booths. Covering biopharmaceutical R&D, life science supplies, pharmaceutical experimental instruments, and industrial service sectors, exhibitors were able to connect their businesses directly with attendees and make connections at the conference.

30th Anniversary Celebration of Molecules
During the conference, we also celebrated the 30th anniversary of Molecules, one of MDPI’s flagship journals. The celebration brought together Section Editors-in-Chief, Editorial Board Members, MDPI leadership, and editorial colleagues to reflect on the journal’s development, achievements, and continued future growth.

Events such as MMCS 2026 highlight the important role conferences play in creating scientific exchange and collaboration, and in connecting our research communities in person.
They also reflect the continued development of MDPI’s conference portfolio and our commitment to supporting academic engagement beyond publishing alone. Thanks to everyone involved in organizing and contributing to the success of this event.
Inside MDPI

Open Access Policies Continue to Accelerate Globally
One of the clearest indicators of the continued momentum behind open access is the growing number of national and institutional policies supporting, and increasingly requiring, open dissemination of research.
Around the world, governments, funding agencies, and universities are building their open access mandates, with increasing focus on transparency, rights retention, and public accessibility of publicly funded research. While these policies vary across regions, the broader direction is clear: expectations around openness and compliance continue to accelerate.
For researchers, navigating these evolving requirements can be complex and time-consuming. Supporting the research community therefore means not only publishing high-quality open access content but also helping stakeholders better understand changing requirements and emerging opportunities. At MDPI, we see this as an important part of our role within scholarly communication.
“Expectations around openness and compliance continue to accelerate”
Through the MDPI Blog, our Content team continues to publish monthly articles overviewing different countries’ relationships with open access, exploring their histories, policies, opportunities, and statistics. All this information is centralized into an article which contains brief summaries of each country, with links to all the full articles, and is updated monthly.
Recent Policy Developments
South Africa
In 2026, South Africa’s Department of Science and Innovation introduced the South African Open Science Policy. The policy states that: “Open access shall be required for publications arising from publicly funded research, and desirable for research from all sources of funding.”
The policy envisions a coordinated and broad approach to open science that will sustainably and ethically drive socio-economic development by increasing the practice of open science through policy, training, incentivization, and infrastructure.
Canada
In Canada, the Tri-Agency OA Policy on Publications was revised, removing the 12-month embargo for research that must be deposited in a repository with an open license and with author rights retained.
The Agencies argue that “societal advancement is made possible through widespread and barrier-free access to cutting-edge research and knowledge.”
Chile
Chile is a collaborative and engaged member of the global open access movement.
The National Research and Development Agency (Agencia Nacional de Investigación y Desarrollo, or ANID) is Chile’s main funding agency for R&D. It mandates that all beneficiaries must deposit the final version of their published scientific output, with an embargo period of up to 12 months, into a repository.
ANID also supports the InES Open Science funding program, which allows universities to request funding for capacity and infrastructure building. Further, Chile is an active participant in various international initiatives, such as Redalyc, SciELO, and Red de Repositorios Latinoamericanos.
Openness Beyond Research
At MDPI, openness remains one of our core values, ensuring that research outputs are freely accessible to anyone. This commitment also extends to sharing knowledge about the scholarly publishing landscape itself, which we practice on the MDPI Blog through various topics, including open access, recent advances in science, and opportunities for researchers.
As the open access landscape continues to evolve, helping researchers, institutions, editors, and partners navigate these changes will remain an important priority for us.

Thank You
I would like to thank Jack McKenna (Senior Content Specialist, MDPI) from our Content team for his ongoing work on the MDPI Blog series covering global open access policy developments. Initiatives such as this help make complex policy discussions more accessible and useful to the wider research community.
Coming Together for Science

Reflections from the MDPI Spain Summit 2026 in Valencia (21 May)

On 21 May, we hosted the MDPI Spain Summit 2026 in Valencia.
The Summit brought together 30 Editorial Board Members and MDPI colleagues for a discussions on the future of publishing, research integrity, peer review, artificial intelligence, and the evolving research landscape in Spain.
We hosted participants from leading Spanish institutions and spoke on the importance of Spain as a major contributor to global open access (OA) research. In 2025 alone, Spain ranked among the leading countries worldwide for OA publishing, with more than 85% of publications made openly accessible. MDPI also continues to play a significant role within the Spanish research ecosystem.
MDPI in Spain
Spain remains one of MDPI's most important academic markets and a leading contributor to OA research globally. Ever since our Barcelona office opened in 2016 (Happy 10th Anniversary!), MDPI Spain has been actively supporting researchers, institutions, societies, and academic partners across the country. Today, the office plays an important role in creating engagement with the Spanish scholarly community through editorial support, partnerships, conferences, training initiatives, and outreach activities.
A cluster of high-level indicators highlight both the strength of the local research ecosystem and MDPI’s role within it:
- 43,218 total publications in Spain in 2025, of which 35,728 (83%) were open access (49% Gold OA).
- 211,200+ total publications (2021–2025), with 84% published open access.
- 13,444 MDPI publications from Spanish institutions in 2025, representing 14% of all open access publications in Spain.
- More than115,100 MDPI publications from Spanish institutions since 1996.
- More than 4,500 Editorial Board Members from Spain, including more than 150 Chief Editors and 57 Associate Editors.
- 42 institutional partners participating in MDPI’s Institutional Open Access Program (IOAP).
- Spain ranks second globally for MDPI society affiliations, with 26 affiliated society agreements currently in place.
Program Overview
What made this summit special was the openness of the discussions around the research landscape in Spain and the role MDPI plays within the market. General topics of the presentations included:
- MDPI Introduction – Stefan Tochev (CEO).
- Engagement with the Academic Community – Dr. Marta Colomer (External Affairs Lead).
- Latest Developments in the Editorial Process – Dr. Jordi Martinez (Deputy Managing Editor).
- Research integrity and Publication Ethics – Slavomir Nikodijevic (Research Integrity Specialist).
- A 360 View of Academic Publishing – Prof. Dr. Luis Angel Ruiz Fernandez (EBM of Remote Sensing).
|
|
|
|
|
|
|
|
Panel Discussion
We also hosted a panel discussion moderated by Marta, entitled “The Future of Academic Publishing” with Prof. Luis Ruiz, Prof. Marta Feliz (EBM of the journal Catalysts), Dr. Enric Sayas (Product Owner, AI & Technology Innovation), and myself. The discussion looked at the evolving role of editors, the future of peer review, and the growing importance of maintaining trust, ethics, and research integrity in an era increasingly influenced by artificial intelligence.
|
|
|
|
Themes from the Summit
Several themes emerged throughout the discussions, reflecting broader conversations taking place across publishing:
- The academic community values efficient publishing workflows, but expectations around scientific quality and editorial rigor continue to rise.
- Reviewer fatigue and long-term sustainability of peer review remain major challenges across the industry.
- AI is rapidly changing scholarly communication and requires transparent and responsible governance.
- Reputation and trust continue to depend on long-term engagement, transparency, and quality-focused decision-making.
“Maintaining an open dialogue with researchers, editors, reviewers, and institutions remains a priority for MDPI”
It was constructive to see the willingness of participants to engage directly and candidly with us. These conversations provide insights that help inform how we continue to develop our editorial processes, engagement activities, and support for the research community. While certain discussions included concerns, there was also recognition that open dialogue between publishers and the research community is essential if we want to improve scholarly communication together.
|
|
|
|
Events such as this are increasingly important for MDPI. They allow us to present our perspective, to listen to the experiences, expectations, and concerns of editors, reviewers, and researchers, and to address these accordingly.
Thank You
Thank you to our Barcelona Office and all colleagues involved in organizing the summit, as well as all participants for contributing to these thoughtful and constructive discussions.
|
|
|
|
|
|
|
|
As publishing continues to evolve, maintaining an open dialogue with researchers, editors, reviewers, and institutions remains an important priority for MDPI. Events such as the Spain Summit play an important role in helping us to build relationships, foster trust, and better understand the needs of our community.
Closing Thoughts

Highlights from Antibiotics 2026 in Barcelona (11–14 May)
This week, MDPI hosted the Antibiotics 2026 — Advances in Antimicrobial Action and Resistance conference in Barcelona, bringing together academics and industry experts to discuss one of the most important scientific and public health challenges of our time: antimicrobial resistance.
The conference welcomed 145 attendees from 42 different countries and territories, alongside 265 submissions and 127 accepted abstracts, showing the international reach of the event and the strong scientific interest in this rapidly evolving field.

Scientific Exchange on a Global Challenge
Antimicrobial resistance continues to be a global concern, creating collaboration across disciplines, institutions, and regions. The conference program focused on a range of topics including:
- Antimicrobial resistance mechanisms
- One Health approaches to antimicrobial stewardship
- Discovery of novel antimicrobial agents
- Innovation in clinical strategies and treatment approaches
- Ethnopharmacology and emerging therapies
Through keynote plenaries, invited lectures, oral presentations, and poster sessions, the conference created a platform for dialogue and scientific exchange.
|
|
|
International Participation and Collaboration
One of the highlights of the event was the diversity of participation across both geography and expertise. Researchers and speakers from Europe, North America, Asia, Africa, Australia, and Latin America took part in discussions throughout the conference, highlighting the global nature of both the challenge and the scientific response.
The scientific program included:
- 2 keynote speakers
- 10 invited speakers
- 36 selected talks
- 78 posters
The conference brought together perspectives from academia, healthcare, and industry, helping facilitate interdisciplinary collaboration around future approaches to antimicrobial research and resistance management.
|
|
|
|
The Role of Conferences in Scholarly Communication
Conferences are an important platform for collaboration, scientific exchange, and community-building. Events such as Antibiotics 2026 show the value of bringing researchers together in person to discuss emerging challenges, share new findings, and strengthen international networks across disciplines and regions.

Thank You
I would like to thank the conference chairs, speakers, participants, sponsors, and the entire MDPI conference team for their work in making this event a success. The engagement and positive feedback from attendees highlight the importance of our events in addressing some of the most pressing scientific challenges facing society today.

Chief Executive Officer
MDPI AG
26 May 2026
Biomolecules | Highly Cited Papers in 2025–2026 in the “Molecular Reproduction” Section
As all articles published in our journal are open access, you have free, unlimited access to the full text. We invite you to read our most highly cited papers published in 2025 and 2026, which are listed below:
1. “HOXA10 and HOXA11 in Human Endometrial Benign Disorders: Unraveling Molecular Pathways and Their Impact on Reproduction”
by Lorin-Manuel Pîrlog, Andrada-Adelaida Pătrășcanu, Mara-Diana Ona, Andreea Cătană and Ioana Cristina Rotar
Biomolecules 2025, 15(4), 563; https://doi.org/10.3390/biom15040563
Full text available online: https://www.mdpi.com/2218-273X/15/4/563
2. “Molecular Biomarkers for Timely and Personalized Prediction of Maternal-Fetal Health Risk”
by Daniel Estrela, Rita F. Santos, Alice Masserdotti, Antonietta Silini, Ornella Parolini, Inês Mendes Pinto and Andrea Cruz
Biomolecules 2025, 15(3), 312; https://doi.org/10.3390/biom15030312
Full text available online: https://www.mdpi.com/2218-273X/15/3/312
3. “Revolutionizing Implantation Studies: Uterine-Specific Models and Advanced Technologies”
by Shu-Yun Li and Francesco John DeMayo
Biomolecules 2025, 15(3), 450; https://doi.org/10.3390/biom15030450
Full text available online: https://www.mdpi.com/2218-273X/15/3/450
4. “Blastocyst-Derived Lactate as a Key Facilitator of Implantation”
by Kathryn H. Gurner and David K. Gardner
Biomolecules 2025, 15(1), 100; https://doi.org/10.3390/biom15010100
Full text available online: https://www.mdpi.com/2218-273X/15/1/100
5. “Conceptus Elongation, Implantation, and Early Placental Development in Species with Central Implantation: Pigs, Sheep, and Cows”
by Gregory A. Johnson, Thainá Minela, Heewon Seo, Fuller W. Bazer, Robert C. Burghardt, Guoyao Wu, Ky G. Pohler, Claire Stenhouse, Joe W. Cain, Zachary K. Seekford et al.
Biomolecules 2025, 15(7), 1037; https://doi.org/10.3390/biom15071037
Full text available online: https://www.mdpi.com/2218-273X/15/7/1037
6. “LIFR-Mediated ERBB2 Signaling Is Essential for Successful Embryo Implantation in Mice”
by Jumpei Terakawa, Sakura Nakamura, Mana Ohtomo, Saki Uehara, Yui Kawata, Shunsuke Takarabe, Hibiki Sugita, Takafumi Namiki, Atsuko Kageyama, Michiko Noguchi et al.
Biomolecules 2025, 15(5), 698; https://doi.org/10.3390/biom15050698
Full text available online: https://www.mdpi.com/2218-273X/15/5/698
7. “Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration”
by Julia Delenko, Nathaniel Hyman, Prodyot K. Chatterjee, Polona Safaric Tepes, Andrew J. Shih, Xiangying Xue, Jane Gurney, Andrew G. Baker, Cheng Wei, Daniel Munoz Espin et al.
Biomolecules 2025, 15(6), 873; https://doi.org/10.3390/biom15060873
Full text available online: https://www.mdpi.com/2218-273X/15/6/873
8. “Unraveling the Multi-Omic Landscape of Extracellular Vesicles in Human Seminal Plasma”
by Laura Governini, Alesandro Haxhiu, Enxhi Shaba, Lorenza Vantaggiato, Alessia Mori, Marco Bruttini, Francesca Loria, Natasa Zarovni, Paola Piomboni, Claudia Landi et al.
Biomolecules 2025, 15(6), 836; https://doi.org/10.3390/biom15060836
Full text available online: https://www.mdpi.com/2218-273X/15/6/836
9. “The Role of Preconception Parental Health on Embryo Quality—Preliminary Results of a Prospective Study Using Non-Invasive Preimplantation Genetic Testing for Aneuploidy”
by Maja Tomic, Eda Bokal-Vrtacnik and Martin Stimpfel
Biomolecules 2025, 15(9), 1215; https://doi.org/10.3390/biom15091215
Full text available online: https://www.mdpi.com/2218-273X/15/9/1215
by Xinyu Wang, Diqi Yang and Hui Peng
Biomolecules 2025, 15(7), 925; https://doi.org/10.3390/biom15070925
Full text available online: https://www.mdpi.com/2218-273X/15/7/925
26 May 2026
Biomolecules | Highly Cited Papers in 2025–2026 in the “Molecular Biomarkers” Section
As all articles published in our journal are open access, you have free, unlimited access to the full text. We invite you to read our most highly cited papers published in 2025 and 2026, which are listed below:
1. “A Comprehensive Oncological Biomarker Framework Guiding Precision Medicine”
by Reza Bayat Mokhtari, Manpreet Sambi, Faezeh Shekari, Kosar Satari, Roya Ghafoury, Neda Ashayeri, Paige Eversole, Narges Baluch, William W. Harless, Lucia Anna Muscarella et al.
Biomolecules 2025, 15(9), 1304; https://doi.org/10.3390/biom15091304
Full text available online: https://www.mdpi.com/2218-273X/15/9/1304
2. “Epigenetic Biomarkers in Thoracic Aortic Aneurysm, Dissection, and Bicuspid Aortopathy: A Comprehensive Review”
by Dimitrios E. Magouliotis, Serge Sicouri, Noah Sicouri, Massimo Baudo, Francesco Cabrucci, Yoshiyuki Yamashita and Basel Ramlawi
Biomolecules 2025, 15(4), 568; https://doi.org/10.3390/biom15040568
Full text available online: https://www.mdpi.com/2218-273X/15/4/568
3. “The Impact of the Microbiota on the Immune Response Modulation in Colorectal Cancer”
by Ana Iulia Neagu, Marinela Bostan, Vlad Alexandru Ionescu, Gina Gheorghe, Camelia Mia Hotnog, Viviana Roman, Mirela Mihaila, Simona Isabelle Stoica, Camelia Cristina Diaconu, Carmen Cristina Diaconu et al.
Biomolecules 2025, 15(7), 1005; https://doi.org/10.3390/biom15071005
Full text available online: https://www.mdpi.com/2218-273X/15/7/1005
4. “Gene Expression Analysis and Validation of a Novel Biomarker Signature for Early-Stage Lung Adenocarcinoma”
by Sanjan S. Sarang, Catherine M. Cahill and Jack T. Rogers
Biomolecules 2025, 15(6), 803; https://doi.org/10.3390/biom15060803
Full text available online: https://www.mdpi.com/2218-273X/15/6/803
5. “Impact of Aging and Pathologies on Human Oral Mucosa: Preliminary Investigation of Biophysical Markers from Thermal and Vibrational Analyses”
by Valérie Samouillan, Camille Ober and Marie-Hélène Lacoste-Ferré
Biomolecules 2025, 15(7), 978; https://doi.org/10.3390/biom15070978
Full text available online: https://www.mdpi.com/2218-273X/15/7/978
6. “Growth Differentiation Factor 15 Predicts Cardiovascular Events in Peripheral Artery Disease”
by Ben Li, Farah Shaikh, Houssam Younes, Batool Abuhalimeh, Abdelrahman Zamzam, Rawand Abdin and Mohammad Qadura
Biomolecules 2025, 15(7), 991; https://doi.org/10.3390/biom15070991
Full text available online: https://www.mdpi.com/2218-273X/15/7/991
7. “The Prognostic, Predictive and Clinicopathological Implications of KRT81/HNF1A- and GATA6-Based Transcriptional Subtyping in Pancreatic Cancer”
by Michael Guenther, Sai Agash Surendran, Lea Margareta Steinke, Iduna Liou, Melanie Alexandra Palm, Volker Heinemann, Michael Haas, Stefan Boeck and Steffen Ormanns
Biomolecules 2025, 15(3), 426; https://doi.org/10.3390/biom15030426
Full text available online: https://www.mdpi.com/2218-273X/15/3/426
8. “Copeptin as a Biomarker in Chronic Kidney Disease—A Systematic Review and Meta-Analysis”
by Gabi Gazi, Robert Cristian Cruciat, Daniel-Corneliu Leucuta, Nahlah Al Srouji, Stefan-Lucian Popa, Mohamed Ismaiel, Dinu Iuliu Dumitrascu and Abdulrahman Ismaiel
Biomolecules 2025, 15(6), 845; https://doi.org/10.3390/biom15060845
Full text available online: https://www.mdpi.com/2218-273X/15/6/845
9. “Tauopathies: Calmodulin Regulates Tau Hyperphosphorylation and Its Transformation into Disease-Specific Aggregates”
by Danton H. O’Day
Biomolecules 2025, 15(8), 1133; https://doi.org/10.3390/biom15081133
Full text available online: https://www.mdpi.com/2218-273X/15/8/1133
by So Young Lee, Kyungdo Han, Hyuk-Sang Kwon, Eun Sil Koh and Sungjin Chung
Biomolecules 2025, 15(4), 557; https://doi.org/10.3390/biom15040557
Full text available online: https://www.mdpi.com/2218-273X/15/4/557
26 May 2026
Biomolecules | Highly Cited Papers in 2025–2026 in the “Molecular Biology” Section
As all articles published in our journal are open access, you have free, unlimited access to the full text. We invite you to read our most highly cited papers published in 2025 and 2026, which are listed below:
1. “The Balance of MFN2 and OPA1 in Mitochondrial Dynamics, Cellular Homeostasis, and Disease”
by Paola Zanfardino, Alessandro Amati, Mirko Perrone and Vittoria Petruzzella
Biomolecules 2025, 15(3), 433; https://doi.org/10.3390/biom15030433
Full text available online: https://www.mdpi.com/2218-273X/15/3/433
2. “Pathological and Inflammatory Consequences of Aging”
by Mario García-Domínguez
Biomolecules 2025, 15(3), 404; https://doi.org/10.3390/biom15030404
Full text available online: https://www.mdpi.com/2218-273X/15/3/404
3. “Calcium Signaling Dynamics in Vascular Cells and Their Dysregulation in Vascular Disease”
by Chang Dai and Raouf A. Khalil
Biomolecules 2025, 15(6), 892; https://doi.org/10.3390/biom15060892
Full text available online: https://www.mdpi.com/2218-273X/15/6/892
4. “Interplay Between Vascular Dysfunction and Neurodegenerative Pathology: New Insights into Molecular Mechanisms and Management”
by Avanthika Mekala and Hongyu Qiu
Biomolecules 2025, 15(5), 712; https://doi.org/10.3390/biom15050712
Full text available online: https://www.mdpi.com/2218-273X/15/5/712
5. “The Role of IL-6 in Ischemic Stroke”
by Hanna Pawluk, Alina Woźniak, Agnieszka Tafelska-Kaczmarek, Agnieszka Kosinska, Mateusz Pawluk, Krzysztof Sergot, Renata Grochowalska and Renata Kołodziejska
Biomolecules 2025, 15(4), 470; https://doi.org/10.3390/biom15040470
Full text available online: https://www.mdpi.com/2218-273X/15/4/470
6. “Thyroid Hormones and Metabolism Regulation: Which Role on Brown Adipose Tissue and Browning Process?”
by Laura Sabatino and Cristina Vassalle
Biomolecules 2025, 15(3), 361; https://doi.org/10.3390/biom15030361
Full text available online: https://www.mdpi.com/2218-273X/15/3/361
7. “β-Catenin: A Key Molecule in Osteoblast Differentiation”
by Edyta Wróbel, Piotr Wojdasiewicz, Agnieszka Mikulska and Dariusz Szukiewicz
Biomolecules 2025, 15(7), 1043; https://doi.org/10.3390/biom15071043
Full text available online: https://www.mdpi.com/2218-273X/15/7/1043
8. “Circadian Biomarkers in Humans: Methodological Insights into the Detection of Melatonin and Cortisol”
by Cene Skubic, Urša Zevnik, Katarina Nahtigal, Leja Dolenc Grošelj and Damjana Rozman
Biomolecules 2025, 15(7), 1006; https://doi.org/10.3390/biom15071006
Full text available online: https://www.mdpi.com/2218-273X/15/7/1006
9. “Unravelling the Connection Between Energy Metabolism and Immune Senescence/Exhaustion in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome”
by Jente Van Campenhout, Yanthe Buntinx, Huan-Yu Xiong, Arne Wyns, Andrea Polli, Jo Nijs, Joeri L. Aerts, Thessa Laeremans and Jolien Hendrix
Biomolecules 2025, 15(3), 357; https://doi.org/10.3390/biom15030357
Full text available online: https://www.mdpi.com/2218-273X/15/3/357
10. “Exploring the Antioxidant Roles of Cysteine and Selenocysteine in Cellular Aging and Redox Regulation”
by Marta Pace, Chiara Giorgi, Giorgia Lombardozzi, Annamaria Cimini, Vanessa Castelli and Michele d’Angelo
Biomolecules 2025, 15(8), 1115; https://doi.org/10.3390/biom15081115
Full text available online: https://www.mdpi.com/2218-273X/15/8/1115
11. “Immunohistochemical Detection of PIEZO Ion Channels in the Human Carotid Sinus and Carotid Body”
by Elda Alba, Yolanda García-Mesa, Ramón Cobo, Patricia Cuendias, José Martín-Cruces, Iván Suazo, Graciela Martínez-Barbero, José A. Vega, Olivia García-Suárez and Teresa Cobo
Biomolecules 2025, 15(3), 386; https://doi.org/10.3390/biom15030386
Full text available online: https://www.mdpi.com/2218-273X/15/3/386
12. “Neuroprotective Potential of Origanum majorana L. Essential Oil Against Scopolamine-Induced Memory Deficits and Oxidative Stress in a Zebrafish Model”
by Ion Brinza, Razvan Stefan Boiangiu, Iasmina Honceriu, Ahmed M. Abd-Alkhalek, Samir M. Osman, Omayma A. Eldahshan, Elena Todirascu-Ciornea, Gabriela Dumitru and Lucian Hritcu
Biomolecules 2025, 15(1), 138; https://doi.org/10.3390/biom15010138
Full text available online: https://www.mdpi.com/2218-273X/15/1/138
13. “Oxidative DNA Damage and Repair Dynamics in Multiple Sclerosis: Insights from Comet Assay Kinetics, Base Excision Repair Gene Expression, and Genotype Analysis”
by Beata Filipek, Anna Macieja, Aleksandra Binda, Rafal Szelenberger, Leslaw Gorniak, Elzbieta Miller, Mariola Swiderek-Matysiak, Mariusz Stasiolek, Ireneusz Majsterek and Tomasz Poplawski
Biomolecules 2025, 15(6), 756; https://doi.org/10.3390/biom15060756
Full text available online: https://www.mdpi.com/2218-273X/15/6/756
14. “Progressive Alcohol-Related Brain Atrophy and White Matter Pathology Are Linked to Long-Term Inhibitory Effects on mTOR Signaling”
by Ming Tong, Camilla Homans, William Pelit, Busra Delikkaya and Suzanne M. de la Monte
Biomolecules 2025, 15(3), 413; https://doi.org/10.3390/biom15030413
Full text available online: https://www.mdpi.com/2218-273X/15/3/413
by Zdeněk Fišar and Jana Hroudová
Biomolecules 2025, 15(4), 495; https://doi.org/10.3390/biom15040495
Full text available online: https://www.mdpi.com/2218-273X/15/4/495



















































